Nutrition Business Journal

Alticore-Metagenics Deal Already Producing Big Benefits



Metagenics is already seeing a wide range of tangible benefits following the substantial ownership investment Alticor injected into the practitioner supplement company one year ago, Metagenics Founder and CEO Jeff Katke told Nutrition Business Journal’s Carlotta Mast during the 2010 NBJ Summit. Katke was at the annual CEO gathering to accept an NBJ Deal of the Year award recognizing the Metagenics-Alticor strategic alliance, which Katke said is helping Metagenics reach new international markets and take a bigger bite out of the chronic disease epidemic spreading around the globe.

Discuss this article 0

Post new comment
Sign In or register to use your New Hope 360 ID
(optional)

 


The Engredea Monograph is a monthly report filled with exclusive content on an ingredient or ingredient category, and includes market data, science, intelligence and in-depth coverage.

Available Now:

China Edition
Carotenoids
Omega-3s
Probiotics
Antioxidants
Sweeteners

See upcoming topics...

 
Connect with Engredea
Upcoming Events
RSS